These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 742946)

  • 21. Purification and characterization of the 1q subcomponent of canine complement and its use in the 125I-C1q binding assay for detection of immune complexes.
    Wu CC; Bey RF; Loken KI
    Am J Vet Res; 1988 Jun; 49(6):865-9. PubMed ID: 3135770
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-human C1q: rapid and simple method for preparing monospecific antisera.
    Yonemasu K
    J Immunol Methods; 1975 Dec; 9(2):185-94. PubMed ID: 812922
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Purification and characterization of subcomponent C1q of the first component of bovine complement.
    Campbell RD; Booth NA; Fothergill JE
    Biochem J; 1979 Feb; 177(2):531-40. PubMed ID: 219845
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of C1q-bearing immune complexes by a monoclonal anti-C1q ELISA system.
    Antes U; Heinz HP; Loos M
    J Immunol Methods; 1987 Sep; 102(2):149-56. PubMed ID: 2443573
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The levels of the male serum and seminal fluid prolactin in oligospermia and azoospermia.
    Suchanek E; Longhino N
    Int J Fertil; 1981; 26(2):128-31. PubMed ID: 6114065
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assay, purification and further characterization of 7S C1q-precipitins (C1q-p) in hypocomplementemic vasculitis urticaria syndrome and systemic lupus erythematosus.
    Marder RJ; Potempa LA; Jones JV; Toriumi D; Schmid FR; Gewurz H
    Acta Pathol Microbiol Immunol Scand Suppl; 1984; 284():25-34. PubMed ID: 6375256
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction of C1q subcomponent with immunoglobulin M.
    Kimak E; Tomaszewski JJ
    Acta Biochim Pol; 1986; 33(3):179-85. PubMed ID: 2433858
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunoglobulin levels in seminal plasma of oligospermic patients.
    Prelević GM; Vircburger MI; Vukotić M; Cuperlović K; Milović V; Petrović M
    Ann Immunol (Paris); 1982; 133D(3):335-8. PubMed ID: 7165283
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of levels of circulating C1q binding macromolecules with induction chemotherapy response in head and neck cancer patients.
    Schantz SP; Savage HE; Brown BW; Reuben JM; Hong WK; Rossen RD
    Cancer Res; 1988 Oct; 48(20):5868-73. PubMed ID: 3262415
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of the first component of human complement, C1, by monoclonal antibodies directed against different domains of subcomponent C1q.
    Kilchherr E; Schumaker VN; Phillips ML; Curtiss LK
    J Immunol; 1986 Jul; 137(1):255-62. PubMed ID: 3486914
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isolation and characterization of mouse C1q.
    McManus LM; Nakane PK
    J Immunol Methods; 1980; 36(2):159-71. PubMed ID: 7430648
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunoglobulins in the semen of men with azoospermia, oligospermia, or self-agglutination of spermatozoa.
    Sullivan H; Quinlivan WL
    Fertil Steril; 1980 Nov; 34(5):465-8. PubMed ID: 7439412
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Binding of soluble immune complexes to Raji lymphocytes. Role of receptors for complement components, C1q and C3-C3b.
    Gupta RC; McDuffie FC; Tappeiner G; Jordon RE
    Immunology; 1978 Apr; 34(4):751-61. PubMed ID: 102587
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of C1 by monoclonal antibodies directed against C1q.
    Kilchherr E; Schumaker VN; Curtiss LK
    Biochem Biophys Res Commun; 1985 Jan; 126(2):785-91. PubMed ID: 3872122
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of immune complex-like materials in cancer patients' sera: a comparative study of results obtained with the C1q deviation and C1q binding tests.
    Rossen RD; Zubler RH; Day NK; Reisberg MA; Morgan AC; Gutterman JU; Hersh EM
    J Lab Clin Med; 1978 Feb; 91(2):191-204. PubMed ID: 413872
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complement-mediated inhibition of immune precipitation. I. Role of the classical and alternative pathways.
    Schifferli JA; Woo P; Peters DK
    Clin Exp Immunol; 1982 Mar; 47(3):555-62. PubMed ID: 6979442
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Interactions between collagen and C1q: their significance for rheumatology].
    Menzel EJ
    Z Rheumatol; 1980; 39(7-8):251-83. PubMed ID: 7006253
    [TBL] [Abstract][Full Text] [Related]  

  • 38. C1q and C1 subcomponent complexes in otitis-prone and non-otitis-prone children. A prospective study of children during their first years of life.
    Prellner K; Sjöholm AG; Harsten G; Heldrup J; Kalm O; Kornfält R
    Acta Paediatr Scand; 1989 Nov; 78(6):911-7. PubMed ID: 2603719
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of the first component of complement, C1, by a monoclonal antibody recognizing the C chain of C1q.
    Heinz HP; Burger R; Golan MD; Loos M
    J Immunol; 1984 Feb; 132(2):804-8. PubMed ID: 6606678
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lack of activation of C1, despite circulating immune complexes detected by two C1q methods, in patients with rheumatoid arthritis.
    Hack CE; Eerenberg-Belmer AJ; Lim UG; Haverman J; Aalberse RC
    Arthritis Rheum; 1984 Jan; 27(1):40-8. PubMed ID: 6318777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.